Response to letters in QoLR
- PMID: 38980638
- DOI: 10.1007/s11136-024-03687-z
Response to letters in QoLR
References
-
- Elsman, E. B. M., Mokkink, L. B., Terwee, C. B., Beaton, D., Gagnier, J. J., Tricco, A. C., Baba, A., Butcher, N. J., Smith, M., Hofstter, C., Aiyegbusi, O. L., Berardi, A., Farmer, J., Haywood, K. L., Krause, K. R., Markham, S., Mayo-Wilson, E., Mehdipour, A., Ricketts, J., … Offringa, M. (2014). Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024. Accepted for co-publication in Quality of Life Research, Journal of Clinical Epidemiology, Journal of Patient-Reported Outcomes, and Health and Quality of Life Outcomes.
-
- FDA. (2022). Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments - guidance for industry, food and drug administration staff, and other stakeholders. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents... .
-
- Mokkink, L. B., Boers, M., van der Vleuten, C. P. M., Bouter, L. M., Alonso, J., Patrick, D. L., de Vet, H. C. W., & Terwee, C. B. (2020). COSMIN risk of bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: A Delphi study. BMC Medical Research Methodology, 20(293). https://doi.org/10.1186/s12874-020-01179-5 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
